Our experience suggests that ADA2 deficiency should be considered as differential diagnosis in cases of severe autoimmune neutropenia evolving to ALPS-like disease not responsive to standard immunosuppressive approaches. The gene discussed is ADA2; the disease is autoimmune lymphoproliferative syndrome.